Replies to post #6199 on AVANIR PHARMACEUTICALS (AVNR)

[expediter13]

There are no experts on IHUB that post what they know. THey lie considering everyone here a gateway to their funds.

10 may still come, no one in the real world expected this to hold 11. 2 - 5% hold their value or increase of 80% off of a phase II trial. Did you expect it too ?

I sold at 11.28 and can just buy back, hoping for lower, can't wait too long as this and concert are going to make a lot of money off of agitation in ALZ...

I consider Concert a steal at these prices and seen some really smart people in the medical community talking about their process... Now that celegene, Avinir and Jazz Pharma are teaming up. The sky is the limit and we can look for other agreement in the DCE Platform. It will make many drugs last longer. That is great, not because it will help patients in the real world because pharma's dont really want to do that...

They want to make money. If I can give a patient one pill a day of "whatever" I can charge more per pill and the costs to mfg are much less...

http://concertpharma.com/research/index.html

I really look for Concert / Avinir to be 100B market cap companies in 10 years, maybe half that in 5. Jazz is already a 9B. Their PPS scares people and they need to do a split, really bad.

[Prudent Capitalist]

Those folks may have been just trying to get folks to think it was going that low, as they were likely shorts trying to talk the stock down. But the markets are the best arbiter of value. I agree with expediter in that we may still see $10, but AVNR has momentum right now.